Caldic has partnered with Elkay Silicones to distribute specialty silicone technologies in India for the paints, coatings, construction and industrial sectors.
The portfolio includes silicone resins, emulsions, additives and hybrid resins that improve durability, water repellency, stain resistance and heat performance, supported by Caldic’s local technical expertise and customer network.
“Elkay Silicones’ specialized technologies complement our existing portfolio and strengthen the solutions we can offer to the coatings and construction markets. By combining their product expertise with our customer reach and solution selling mindset we look forward to developing new opportunities and creating long-term value for our customers.” Smita Shetty, Managing Director at Caldic India
The portfolio includes heat-resistant silicone resins, water-based silicone emulsions and additives, as well as hybrid silicone resins. These technologies can help enhance properties such as water repellency, water beading, stain resistance, anti-graffiti performance and resistance to high temperatures.
The solutions are suitable for applications including architectural paints, construction materials, heat-resistant coatings, powder coatings, industrial finishes and coatings for household appliances.
“As the first Indian manufacturer of high-performance resins for heat-resistant, anti-corrosion, and non-stick applications, Elkay Chemicals is excited to partner with Caldic to accelerate our growth together in the Indian Coatings, Construction, and Industrial markets. This collaboration bridges our innovative Silicone expertise with Caldic’s robust local network and customer solution driven approach, ensuring Indian customers receive the advanced, reliable solutions required to thrive in a rapidly growing specialty chemcial industry.” says Dr. Rahul Kulkarni, PhD, Vice President, Technical at Elkay Chemicals Pvt Ltd.
Note: The headline, insights, and image of this press release may have been refined by the ALCHEMPro staff; the rest of the content remains unchanged.
ALCHEMPro News Desk (JP)
